A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fra... - PubMed - NCBI https://t.co/hpX5HCpG5R #cbd
1,854 followers
105 followers
STUDY: Transdermal #CBD was found to improve the condition of 20 participants with Fragile X syndrome in a clinical trial. Open access paper ⬇ https://t.co/x5dB8d7Et0 #mentalhealth #sciencetwitter #anxiety #behavior #cannabisandmentalhealth @JahanMarcu
3,944 followers
RT @ScienceSaoirse: A positive open label study with #cbd #cannabidiol in #paediatric fragile x syndrome https://t.co/JE4qKVgmR4
4,689 followers
RT @ScienceSaoirse: A positive open label study with #cbd #cannabidiol in #paediatric fragile x syndrome https://t.co/JE4qKVgmR4